LD-2 disclosure · 2nd Quarter - Report (No Activity)
GRITSTONE ONCOLOGY
Coverage · No income or expenses were reported on this filing.
Client
- Description
- Clinical-stage biotechnology company; develops next generation cancer immunotherapies
- Location
- California · United States of America
Registrant
- Description
- lobby firm
- Location
- Washington, District of Columbia, United States of America